Navigation Links
CVS Caremark Developing New Ways to Help Patients Take Medications as Directed
Date:5/26/2011

WASHINGTON, May 26, 2011 /PRNewswire/ -- Researchers at Harvard University, Brigham and Women's Hospital and CVS Caremark today outlined their findings on the issue of medication adherence and made recommendations for how their research to date can be used to help improve the way pharmacy care is delivered in the U.S.  The research collaboration between these groups was announced in the fall of 2009 and was showcased today at a forum at the National Press Club in Washington, D.C. marking the half-way point in the three-year-initiative.  

(Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO)

In addition to reviewing results to date, the research team leaders urged regulators and legislators to renew their focus on making sure people take their medications as directed by their physicians as a way to improve the quality of care and reduce costs for caring for the chronically ill.  Annual excess health care costs due to medication non-adherence in the U.S. have been estimated to be as much as $300 billion annually.

"When we began, we knew our research would expand the science of pharmacy care," said Troyen A. Brennan, MD, MPH executive vice president and chief medical officer of CVS Caremark, who heads the research initiative. "The more we studied the topic, the more we realized that there are steps our industry can take today to improve the rates at which people take their medicines. This is important work because we know if we can improve medication adherence rates, we have a unique opportunity to improve the quality and lower the cost of health care."

"Not surprisingly, we learned there is no single answer to solving the puzzle of adherence, even though this problem has been recognized for decades. But there are practices we can improve upon and programs we can implement that can have an impact. That work can start today," said William H. Shran
'/>"/>

SOURCE CVS Caremark
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CVS Caremark Research Tailors Consumer Communications to Encourage Better Medication Behavior
2. CVS Caremark to Present at the Sanford C. Bernstein Strategic Decisions Conference
3. CVS Caremark to Participate in the Citi Investment Research 2011 Global Consumer Conference
4. CVS Caremark to Pilot Electronic Prior Authorization to Help Speed Patient Access to Prescription Medication
5. CVS Caremark Named as Finalist for 2011 URAC Award for Best Practices in Health Care Consumer Empowerment and Protection
6. CVS Caremark Uniquely Integrated Business Well-Positioned to Deliver Shareholder Value
7. CVS Caremark Reports First Quarter Results
8. CVS Caremark to Complete Acquisition of Universal Americans Medicare Part D Business
9. NCPA Responds to Consumer Groups Request for CVS Caremark Divestiture
10. CVS Caremark to Offer Medical Benefit Drug Management Services to Clients
11. CVS Caremark Insights 2011 Report Highlights Lowest Drug Trend in Six Years and Increased Utilization of Generics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , and MARSEILLE, France , ... , Exclusive global license from University of Tokyo enables ... sequencing (NGS) gene panels, for blood cancers  ... test, indicate favorable prognosis for patients with bone marrow ... potential for developing companion diagnostics to guide treatment with ...
(Date:7/24/2014)... CITY, Calif., July 24, 2014  Abaxis, Inc. (NasdaqGS: ... point-of-care blood analysis systems, today reported financial results for ... First quarter overview: , Revenues of $47.5 ... , Diluted EPS of $0.21, up 50% over last ... Medical market revenues of $7.2 million, up 20% over ...
(Date:7/24/2014)... VIEW, Calif. , July 24, 2014  IRIDEX ... it will release its second quarter 2014 financial results ... 2014. In conjunction with the release, the Company ... at 5:00 p.m. Eastern Time on ... of the quarter and other business developments. ...
Breaking Medicine Technology:QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 2QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 3QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 4QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 2Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 4Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 6Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 7Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 8Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 9Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 10Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 11
... BALTIMORE, June 9, 2011 Paragon Bioservices, Inc., ... announced today that representatives from the company will ... One-on-One Partnering Meetings being held on June 27-30 ... Convention Center. Founded in 1990, ...
... Calif. and OXFORD, Miss., June 9, 2011 ... University of Mississippi today announced the university has granted ... to a potential new therapeutic use for pterostilbene (tero-STILL-bean) ... an ultra-pure formulation of pterostilbene, a compound found in ...
Cached Medicine Technology:Paragon Bioservices to Partner and Exhibit at the 2011 BIO International Convention 2ChromaDex Licenses Additional Technology for pTeroPure® From the University of Mississippi 2ChromaDex Licenses Additional Technology for pTeroPure® From the University of Mississippi 3
(Date:7/24/2014)... a medical device or surgical implant is put inside ... Northwestern University,s Guillermo Ameer, most of the time, that ... , "You will always get an inflammatory response to ... Northwestern,s McCormick School of Engineering and Applied Science and ... "A problem with commonly used plastic materials, in particular, ...
(Date:7/24/2014)... Newark, NJ (PRWEB) July 24, 2014 ... which will give one lucky family a rent-free week ... only until August 3, 2014. Don’t miss your chance ... The sweepstakes is open to all New Jersey residents, ... Horizon BCBSNJ Facebook page, http://www.facebook.com/HorizonBCBSNJ . , ...
(Date:7/24/2014)... IA (PRWEB) July 24, 2014 Members of ... Michael Wolnerman, RPh, CCIM, Senior Associate of Sales at OutcomesMTM, ... Governor appointed him to the Board and that his peers ... “I want to provide the best I can for the ... I am uniquely positioned to provide a special insight to ...
(Date:7/24/2014)... performed during Jewish circumcisions that involves direct oral suction ... type 1 (HSV-1) transmissions documented in infants between 1988 ... Penn Medicine researchers and published online in the ... The reviewers, from Penn,s Center for Evidence-based ... Canada and Israel. , The practiceknown as metzitzah b,pehand ...
(Date:7/24/2014)... 24, 2014 According to market ... Models, Technology Roadmap, Forecasts and Analysis - 2018", ... expected to reach $7.7 billion by 2018 at ... Browse 102 market data tables and 30 figures ... “3D Mapping Market: Global Advancements, Business Models, Technology ...
Breaking Medicine News(10 mins):Health News:Antioxidant biomaterial promotes healing 2Health News:(Beach) Sands of Time Running out to Enter Horizon Blue Cross Blue Shield of New Jersey’s 2014 “Back to the Boardwalk” Sweepstakes 2Health News:Wolnerman Re-elected as Chairperson of Iowa State Board of Health 2Health News:Link between ritual circumcision procedure and herpes infection in infants examined 2Health News:3D Mapping & 3D Modeling Market Projected to $7.7 Billion by 2018 - Report by MarketsandMarkets 2Health News:3D Mapping & 3D Modeling Market Projected to $7.7 Billion by 2018 - Report by MarketsandMarkets 3Health News:3D Mapping & 3D Modeling Market Projected to $7.7 Billion by 2018 - Report by MarketsandMarkets 4
... increased risk for life-threatening cardiovascular diseases, people with type ... advised to monitor their blood sugar levels more than ... study. ,Researchers conducted a meta-analysis of 13 previously ... sugar levels and cardiovascular disease. Results showed that blood ...
... of glycosylated hemoglobin, or HA1c, may be an independent ... // and stroke, according to the new research. Two ... control and the development of heart disease and stroke. ... people, investigators found a 21-percent increase in cardiovascular events ...
... tends to be more severe and resistant to medical ... improvement in symptoms when a full range of medical ... patients with asthma were found to have a higher ... compared to patients without asthma. A higher proportion of ...
... used antibiotic, but new research suggests it could be ... study shows patients should not be given erythromycin along ... because it increases the risk of sudden death. ... is any association between the use of erythromycin and ...
... designed to educate parents about allergens and tobacco smoke ... say researchers .More than 900 children with ... least one indoor environmental allergen and lived in low-income ... areas suffer from the disease at a disproportionately high ...
... to a recent study researchers say the antidepressant ... symptoms of fibromyalgia in women . Duloxetine ... // norepinephrine, two of the brain’s neurotransmitters that ... chronic musculoskeletal disorder that is characterized by body ...
Cached Medicine News:
Anis tying forcep is extra delicate with smooth jaws, curved. For 9-0 to 11-0 sutures....
Curved shafts and tips with tying surfaces. Wide serrated handle with dull finish. Overall length 4.3 inches....
Straight heavy shafts with 7 mm tying surface. Wide serrated handle, polished finish. Overall length 4.2 inches....
Straight shafts with 6 mm tying platform. Serrated handle with polished finish. Most popular size or model. Overall length 4 inches....
Medicine Products: